Inovio’s COVID-19 Vaccine Suggests Overall Immune Responses in Phase I Trial

[unable to retrieve full-text content]INO-4800 is one of the experimental vaccines included in the U.S. government’s Operation Warp Speed that has a goal of having a vaccine available by January 2021.

About the Author: Biotech Today

You might like